Templeton & Phillips Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$367K Hold
306
0.27% 38
2026
Q1
$281K Hold
306
0.23% 46
2025
Q4
$329K Hold
306
0.22% 34
2025
Q3
$233K Hold
306
0.17% 39
2025
Q2
$239K Hold
306
0.17% 35
2025
Q1
$253K Hold
306
0.18% 36
2024
Q4
$236K Hold
306
0.19% 39
2024
Q3
$271K Hold
306
0.21% 35
2024
Q2
$277K Hold
306
0.25% 29
2024
Q1
$238K Buy
+306
New +$218K 0.22% 27

Other funds holding LLY

Templeton & Phillips Capital Management's LLY Position: Q2 2026 in Review

Templeton & Phillips Capital Management held its Eli Lilly (LLY) position steady in Q2 2026 at 306 shares worth $367K. The position accounts for 0.27% of the portfolio, ranked #38.

Templeton & Phillips Capital Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Templeton & Phillips Capital Management held 306 shares of Eli Lilly worth $367K as of Q2 2026.
  • Templeton & Phillips Capital Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.27% of Templeton & Phillips Capital Management's portfolio in Q2 2026, its #38 holding.
  • Templeton & Phillips Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Templeton & Phillips Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.